IHT Wealth Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,964
| Closed | -$202K | – | 1009 |
|
|
2023
Q2 | $202K | Buy |
+4,964
| New | +$202K | 0.01% | 882 |
|
|
2022
Q2 | – | Sell |
-3,292
| Closed | -$239K | – | 789 |
|
|
2022
Q1 | $239K | Buy |
3,292
+92
| +3% | +$6.68K | 0.02% | 651 |
|
|
2021
Q4 | $378K | Buy |
3,200
+495
| +18% | +$58.5K | 0.03% | 524 |
|
|
2021
Q3 | $363K | Sell |
2,705
-3,803
| -58% | -$510K | 0.03% | 532 |
|
|
2021
Q2 | $1.05M | Sell |
6,508
-365
| -5% | -$59.1K | 0.07% | 308 |
|
|
2021
Q1 | $552K | Sell |
6,873
-7,658
| -53% | -$615K | 0.04% | 423 |
|
|
2020
Q4 | $790K | Sell |
14,531
-494
| -3% | -$26.9K | 0.07% | 287 |
|
|
2020
Q3 | $299K | Buy |
15,025
+4,620
| +44% | +$91.9K | 0.03% | 480 |
|
|
2020
Q2 | $219K | Sell |
10,405
-2,100
| -17% | -$44.2K | 0.03% | 494 |
|
|
2020
Q1 | $153K | Buy |
+12,505
| New | +$153K | 0.02% | 497 |
|
|
2019
Q2 | – | Sell |
-10,534
| Closed | -$180K | – | 558 |
|
|
2019
Q1 | $180K | Buy |
10,534
+212
| +2% | +$3.62K | 0.03% | 472 |
|
|
2018
Q4 | $141K | Buy |
10,322
+2,280
| +28% | +$31.1K | 0.03% | 444 |
|
|
2018
Q3 | $230K | Sell |
8,042
-200
| -2% | -$5.72K | 0.05% | 379 |
|
|
2018
Q2 | $226K | Hold |
8,242
| – | – | 0.06% | 358 |
|
|
2018
Q1 | $170K | Buy |
8,242
+200
| +2% | +$4.13K | 0.05% | 380 |
|
|
2017
Q4 | $161K | Hold |
8,042
| – | – | 0.04% | 390 |
|
|
2017
Q3 | $234K | Sell |
8,042
-328
| -4% | -$9.54K | 0.1% | 221 |
|
|
2017
Q2 | $1 | Buy |
8,370
+90
| +1% | – | ﹤0.01% | 1335 |
|
|
2017
Q1 | $117K | Buy |
+8,280
| New | +$117K | 0.08% | 255 |
|